While concerns about overdiagnosis and overtreatment of low-risk tumors from PSA screening remain, AA men benefit most from screening as they exhibit higher PSA levels, earlier disease progression, and are more likely to harbor genomically aggressive prostate cancer [2,6]. Here, KLK3 is linked to prostate carcinoma.